AG-024322 is a multi-targeted CDK inhibitor with potent antitumor activity in vivo
Year: 2005
Type: article
Source: Cancer Research
Authors: Cathy C. Zhang, Gabriel E. Troche, Zhengming Yan, Maria E. Arango, Joseph R. Higgins, David Romero, Susan E. Kephart, Indrawan McAlpine, Tatiana Koudriakova, Judith Skaptason, Jim Nonomiya, Daniel Knighton, Rose Ann Ferre, Jayashree Tikhe, Gennady M. Verkhivker, Meirong Xu, William H. Romines, Cindy Palmer, Julie Park, Siegfried Reich, Gerrit Los, Cristina Lewis
Institution: Pfizer (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2733835459
